WallStreetZenWallStreetZen

NASDAQ: ITOS
Iteos Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ITOS

Based on 1 analyst offering 12 month price targets for Iteos Therapeutics Inc.
Min Forecast
$44.00+287.32%
Avg Forecast
$44.00+287.32%
Max Forecast
$44.00+287.32%

Should I buy or sell ITOS stock?

Based on 1 analyst offering ratings for Iteos Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ITOS stock forecasts and price targets.

ITOS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$44.00+287.32%2023-08-09

1 of 1

Forecast return on equity

Is ITOS forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%

Forecast return on assets

Is ITOS forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%

ITOS revenue growth forecast

How is ITOS forecast to perform vs Biotechnology companies and vs the US market?
Company
-13.37%
Industry
35.17%
Market
8.14%
ITOS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ITOS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ITOS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ITOS$11.36$44.00+287.32%Buy
AUTL$2.34$7.50+220.51%Strong Buy
LQDA$6.31$12.33+95.45%Hold
ICVX$8.20$27.00+229.27%Buy
NRIX$8.52$26.60+212.21%Buy
View Top Biotech Stocks

Iteos Therapeutics Stock Forecast FAQ

Is Iteos Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ITOS) stock is to Buy ITOS stock.

Out of 1 analyst, 0 (0%) are recommending ITOS as a Strong Buy, 1 (100%) are recommending ITOS as a Buy, 0 (0%) are recommending ITOS as a Hold, 0 (0%) are recommending ITOS as a Sell, and 0 (0%) are recommending ITOS as a Strong Sell.

If you're new to stock investing, here's how to buy Iteos Therapeutics stock.

What is ITOS's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ITOS) forecast ROE is N/A, which is considered weak.

What is ITOS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ITOS price target, the average ITOS price target is $44.00, with the highest ITOS stock price forecast at $44.00 and the lowest ITOS stock price forecast at $44.00.

The Wall Street analyst predicted that Iteos Therapeutics's share price could reach $44.00 by Aug 9, 2024. The average Iteos Therapeutics stock price prediction forecasts a potential upside of 287.32% from the current ITOS share price of $11.36.

What is ITOS's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ITOS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.